Internal Versus External Tocodynamometry and Labor Outcome
Study Details
Study Description
Brief Summary
In this study, parturients will be randomized to either internal or external tocodynamometry contractions' follow up. Investigators recruit primiparous, those who try to have vaginal birth after cesarean section and multiparous, who need oxytocin during labor. Primary endpoint is the number of operative labors in each group. Secondary endpoints are the duration of labor, the use of oxytocin and the condition of the newborn.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Intrauterine pressure catheter Intrauterine pressure catheter is used during labor to follow up the contractions |
Device: Intrauterine pressure catheter
Other Names:
|
Active Comparator: External tocodynamometry External tocodynamometry is used during labor to follow up the contractions |
Device: External tocodynamometry
|
Outcome Measures
Primary Outcome Measures
- Number of cesarean sections [through study completion, an average of 6 years]
- Number of operative vaginal deliveries [through study completion, an average of 6 years]
Secondary Outcome Measures
- Duration of labor [From time of first regular contraction to birth]
- Newborn admission to the pediatric care unit [3 days after birth]
- The use of Oxytocin during labor [From beginning of the use of oxytocin to the birth]
- Apgar scores [10 min after birth]
- Ph of umbilical artery [immediately after birth]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
gestational age ≥ 37 weeks
-
singleton pregnancy
-
a fetus in cephalic position
-
normal cardiotocograph in the time of randomization
-
cervical ripening < 7 cm
-
either 1) primipara, 2) multipara, who needs oxytocin during first stage of labor or
- parturients with previous cesarean section
Exclusion Criteria:
-
parturient with hepatitis or HIV or other significant viral infection
-
Acute infections (fever over 37,5, or C-reactive protein over 20) in the time of randomization
-
Estimated fetal weight over 4,5 kg
-
Suspected fetal abnormality
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cetral Finland Central Hospital | Jyväskylä | Central Finland | Finland | 40640 |
2 | Tampere University Hospital | Tampere | Pirkanmaa | Finland | 33520 |
Sponsors and Collaborators
- Tampere University Hospital
- Central Finland Hospital District
Investigators
- Principal Investigator: Tuija Hautakangas, MD, Central Finland Central Hospital, Tampere University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- R12229